We are live on ! Find out more
FCM

Frontier Capital Management Portfolio holdings

AUM $9.73B
1-Year Est. Return 55.65%
This Fund
S&P 500
This Quarter Est. Return
+7.14%
1 Year Est. Return
+55.65%
3 Year Est. Return
+154.46%
5 Year Est. Return
+213.15%
10 Year Est. Return
+1,202.39%
AUM
$10.5B
AUM Growth
-$101M
Cap. Flow
-$274M
Cap. Flow %
-2.6%
Top 10 Hldgs %
15.8%
Holding
307
New
26
Increased
94
Reduced
161
Closed
22

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$91.9M
2
CG icon
Carlyle Group
CG
+$61.9M
3
ZS icon
Zscaler
ZS
+$44.7M
4
CZR icon
Caesars Entertainment
CZR
+$42.2M
5
BILL icon
BILL Holdings
BILL
+$39.7M

Sector Composition

Rank Sector Weight
1 Technology 24%
2 Industrials 21.29%
3 Consumer Discretionary 13.52%
4 Healthcare 13.05%
5 Financials 12.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVN icon
251
Devon Energy
DVN
$51.2B
$5.73M 0.05%
174,960
-465
-0.3% -$17.5K
RVTY icon
252
Revvity
RVTY
$12.6B
$5.61M 0.05%
50,278
+5,829
+13% +$685K
NXT icon
253
Nextpower Inc
NXT
$13.8B
$5.3M 0.05%
144,975
-200
-0.1% -$7.33K
TER icon
254
Teradyne
TER
$58.3B
$4.94M 0.05%
+39,239
New +$4.64M
ACHC icon
255
Acadia Healthcare
ACHC
$2.73B
$4.91M 0.05%
+123,891
New +$5.59M
AMPH icon
256
Amphastar Pharmaceuticals
AMPH
$879M
$4.58M 0.04%
123,360
-259
-0.2% -$11.8K
INCY icon
257
Incyte
INCY
$24.3B
$4.55M 0.04%
65,811
-148
-0.2% -$10.5K
AXSM icon
258
Axsome Therapeutics
AXSM
$11.3B
$4.46M 0.04%
52,768
-67,772
-56% -$6.23M
SRPT icon
259
Sarepta Therapeutics
SRPT
$1.59B
$4.32M 0.04%
35,562
-4,735
-12% -$580K
JAZZ icon
260
Jazz Pharmaceuticals
JAZZ
$15.9B
$4.31M 0.04%
35,002
+11,027
+46% +$1.3M
PAY icon
261
Paymentus
PAY
$4.22B
$4.2M 0.04%
128,633
+69,896
+119% +$2.08M
HQY icon
262
HealthEquity
HQY
$8.42B
$4.2M 0.04%
+43,760
New +$4.08M
ICLR icon
263
Icon
ICLR
$12.7B
$4.02M 0.04%
+19,177
New +$4.48M
LRN icon
264
Stride
LRN
$3.43B
$3.48M 0.03%
33,445
-43,342
-56% -$4.12M
SGML icon
265
Sigma Lithium
SGML
$1.09B
$3.45M 0.03%
307,512
+48,852
+19% +$639K
ENVX icon
266
Enovix
ENVX
$870M
$3.4M 0.03%
+357,133
New +$3.13M
SSYS icon
267
Stratasys
SSYS
$683M
$3.29M 0.03%
370,137
+21,977
+6% +$189K
FIP icon
268
FTAI Infrastructure
FIP
$441M
$2.86M 0.03%
+393,851
New +$3.38M
EOLS icon
269
Evolus
EOLS
$379M
$2.65M 0.03%
+239,811
New +$3.37M
PENG
270
Penguin Solutions Inc
PENG
$2.65B
$2.6M 0.02%
135,303
-19,157
-12% -$350K
ALGM icon
271
Allegro MicroSystems
ALGM
$7.82B
$1.99M 0.02%
+91,194
New +$1.94M
NET icon
272
Cloudflare
NET
$98.8B
$1.01M 0.01%
9,411
+6,782
+258% +$663K
PATH icon
273
UiPath
PATH
$6.52B
$995K 0.01%
78,270
-221,189
-74% -$2.92M
INSW icon
274
International Seaways
INSW
$4.73B
$615K 0.01%
17,123
-211,371
-93% -$8.99M
CAVA icon
275
CAVA Group
CAVA
$7.7B
$572K 0.01%
5,075
+203
+4% +$27.1K

Similar funds

Frontier Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Frontier Capital Management held 307 positions worth $10.5B, down 0.95% from $10.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Frontier Capital Management's Q4 2024 filing shows 26 new, 94 increased, 161 reduced and 22 closed positions. Its largest new stake was Applovin: 363,178 shares worth $118M. The largest sale was Summit Materials, Inc. Class A Common Stock, an estimated $123M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Frontier Capital Management's largest Q4 2024 buy was Applovin: 363,178 shares worth $118M.
  • Frontier Capital Management added most to Carlyle Group in Q4 2024, an estimated $61.9M increase.
  • Frontier Capital Management's biggest Q4 2024 reduction was Summit Materials, Inc. Class A Common Stock, cutting an estimated $123M.
  • Frontier Capital Management fully exited Halozyme in Q4 2024, selling an estimated $72.7M.
  • Frontier Capital Management's ten largest holdings make up 16% of its $10.5B portfolio in Q4 2024.
  • Frontier Capital Management opened 26 new positions and closed 22 in Q4 2024.
  • Frontier Capital Management's portfolio value fell 0.95% quarter-over-quarter to $10.5B.

Based on Frontier Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.